Insider · CIK 0001719461

Greenberg Richard S

Reports to the SEC for 1 company · GLENDALE, CO

sec.gov

Transactions

Companies

Filings

CIK

0001719461

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-23	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+1M sh	—	—	7,185,193
2023-10-31	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	6,185,193
2023-07-25	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	5,935,193
2023-04-01	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	5,685,193
2023-01-17	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	5,435,193
2022-10-17	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	5,185,193
2022-07-27	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	4,935,193
2022-04-20	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	4,685,193
2022-01-27	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+250K sh	—	—	4,435,192
2021-11-29	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+500K sh	—	—	4,185,192
2021-04-01	NEXIEN BIOPHARMA, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+1M sh	—	—	3,685,192
2020-11-24	NEXIEN BIOPHARMA, INC.Convertible noteA Award	Director, Chief Executive Officer, 10% Owner	AAward	—	—	—	—
2020-11-24	NEXIEN BIOPHARMA, INC.Class A WarrantA Award	Director, Chief Executive Officer, 10% Owner	AAward	+1.06M sh	—	—	1,062,953
2020-11-24	NEXIEN BIOPHARMA, INC.Class B WarrantA Award	Director, Chief Executive Officer, 10% Owner	AAward	+1.06M sh	—	—	1,062,953
2020-11-24	NEXIEN BIOPHARMA, INC.Class C WarrantA Award	Director, Chief Executive Officer, 10% Owner	AAward	+1.06M sh	—	—	1,062,953
2020-08-19	NEXIEN BIOPHARMA, INC.Stock option - right to buyA Award	Director, Chief Executive Officer, 10% Owner	AAward	+2.5M sh	—	—	2,500,000
2020-08-12	NEXIEN BIOPHARMA, INC.C Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	+1.8M sh	$0.01	+$25.2K	2,685,192
2020-08-12	NEXIEN BIOPHARMA, INC.C Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	+1.8M sh	$0.01	+$25.2K	2,688,880
2018-10-26	NEXIEN BIOPHARMA, INC.Options to purchase common stock (right to buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	+100K sh	—	—	100,000
2018-07-25	NEXIEN BIOPHARMA, INC.Stock option - right to buyA Award	Director, Chief Executive Officer, 10% Owner	AAward	+150K sh	—	—	150,000
2018-06-28	NEXIEN BIOPHARMA, INC.X Exercise of In-Money	Director, Chief Executive Officer, 10% Owner	XExercise of In-Money	+88K sh	$0.38	+$33.4K	888,000
2018-06-28	NEXIEN BIOPHARMA, INC.Class B Warrants (right to buy)X Exercise of In-Money	Director, Chief Executive Officer, 10% Owner	XExercise of In-Money	−88K sh	—	—	0
2018-06-28	NEXIEN BIOPHARMA, INC.X Exercise of In-Money	Director, Chief Executive Officer, 10% Owner	XExercise of In-Money	+88K sh	$0.38	+$33.4K	888,000
2018-06-28	NEXIEN BIOPHARMA, INC.Class B Warrants (right to buy)X Exercise of In-Money	Director, Chief Executive Officer, 10% Owner	XExercise of In-Money	−88K sh	—	—	0
2018-06-27	NEXIEN BIOPHARMA, INC.Class B Warrants (right to buy)J Other	Director, Chief Executive Officer, 10% Owner	JOther	+88K sh	—	—	88,000
2018-06-27	NEXIEN BIOPHARMA, INC.Class B Warrants (right to buy)J Other	Director, Chief Executive Officer, 10% Owner	JOther	+88K sh	—	—	88,000
2017-11-29	NEXIEN BIOPHARMA, INC.J Other	Director, Chief Executive Officer, 10% Owner	JOther	+15.1M sh	—	—	24,000,000
2017-11-29	NEXIEN BIOPHARMA, INC.J Other	Director, Chief Executive Officer, 10% Owner	JOther	+503K sh	—	—	800,000
2017-10-13	NEXIEN BIOPHARMA, INC.J Other	Director, Chief Executive Officer, 10% Owner	JOther	−20M sh	—	—	0
2017-10-13	NEXIEN BIOPHARMA, INC.J Other	Director, Chief Executive Officer, 10% Owner	JOther	+53.4M sh	—	—	53,405,501
2017-10-13	NEXIEN BIOPHARMA, INC.J Other	Director, Chief Executive Officer, 10% Owner	JOther	+1.78M sh	—	—	1,780,183

Recent filings

Accepted (ET)
May 284
Greenberg Richard S0001214659-24-010007
SEC(opens sec.gov)
Nov 24
Greenberg Richard S0001214659-23-014445
SEC(opens sec.gov)
Jul 314
Greenberg Richard S0001214659-23-010505
SEC(opens sec.gov)
Apr 194
Greenberg Richard S0001214659-23-005656
SEC(opens sec.gov)
Jan 174
Greenberg Richard S0001214659-23-000681
SEC(opens sec.gov)
Oct 184
Greenberg Richard S0001214659-22-012392
SEC(opens sec.gov)
Sep 154
Greenberg Richard S0001214659-22-011159
SEC(opens sec.gov)
Jan 314
Greenberg Richard S0001214659-22-001420
SEC(opens sec.gov)
Nov 294
Greenberg Richard S0001214659-21-012346
SEC(opens sec.gov)
Apr 54
Greenberg Richard S0001214659-21-003943
SEC(opens sec.gov)
Nov 304
Greenberg Richard S0001214659-20-009996
SEC(opens sec.gov)
Aug 254/A
Greenberg Richard S0001214659-20-007471
SEC(opens sec.gov)
Aug 214
Greenberg Richard S0001214659-20-007419
SEC(opens sec.gov)
Aug 144
Greenberg Richard S0001214659-20-007221
SEC(opens sec.gov)
Oct 294
Greenberg Richard S0001214659-18-006682
SEC(opens sec.gov)
Jul 264
Greenberg Richard S0001214659-18-004983
SEC(opens sec.gov)

Companies

NEXIEN BIOPHARMA, INC.Director, Chief Executive Officer, 10% Owner

Address

4340 E KENTUCKY AVE SUITE 206

GLENDALE, CO, 80246